These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 7629404)
21. Daily blood pressure control is not sufficient to regress cardiac hypertrophy and dysfunction: a bi-ventricular tissue Doppler echocardiographic study. Balal M; Koc M; Paydas S; Demir E; Sertdemir Y; Acarturk E Nephrology (Carlton); 2007 Apr; 12(2):140-6. PubMed ID: 17371336 [TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and cardiovascular complications in patients with essential hypertension. Kamide K; Nagano M; Nakano N; Yo Y; Kobayashi R; Rakugi H; Higaki J; Ogihara T Am J Hypertens; 1996 Dec; 9(12 Pt 1):1165-71. PubMed ID: 8972886 [TBL] [Abstract][Full Text] [Related]
23. Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later. Arnlöv J; Lind L; Sundström J; Andrén B; Vessby B; Lithell H Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):242-9. PubMed ID: 16054547 [TBL] [Abstract][Full Text] [Related]
24. Relation of insulin resistance and left ventricular function and structure in non-diabetic patients with essential hypertension. Evrengul H; Dursunoglu D; Kaftan A; Kilicaslan F; Tanriverdi H; Kilic M Acta Cardiol; 2005 Apr; 60(2):191-8. PubMed ID: 15887476 [TBL] [Abstract][Full Text] [Related]
25. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Paolisso G; Tagliamonte MR; Galderisi M; Zito GA; Petrocelli A; Carella C; de Divitiis O; Varricchio M Hypertension; 1999 Nov; 34(5):1047-52. PubMed ID: 10567180 [TBL] [Abstract][Full Text] [Related]
26. Type A behavior is associated with an increased risk of left ventricular hypertrophy in male patients with essential hypertension. Munakata M; Hiraizumi T; Nunokawa T; Ito N; Taguchi F; Yamauchi Y; Yoshinaga K J Hypertens; 1999 Jan; 17(1):115-20. PubMed ID: 10100102 [TBL] [Abstract][Full Text] [Related]
27. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy]. Amici E; Patruno N; Natale E; Marsocci A; Gambelli G Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388 [TBL] [Abstract][Full Text] [Related]
28. Left ventricular hypertrophy and preclinical impaired glucose tolerance and diabetes mellitus contribute to abnormal left ventricular diastolic function in hypertensive patients. Salmasi AM; Rawlins S; Dancy M Blood Press Monit; 2005 Oct; 10(5):231-8. PubMed ID: 16205440 [TBL] [Abstract][Full Text] [Related]
29. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy. Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681 [TBL] [Abstract][Full Text] [Related]
30. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension. Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037 [TBL] [Abstract][Full Text] [Related]
32. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525 [TBL] [Abstract][Full Text] [Related]
33. Relationship of central and peripheral blood pressure to left ventricular mass in hypertensive patients. Pérez-Lahiguera FJ; Rodilla E; Costa JA; Gonzalez C; Martín J; Pascual JM Rev Esp Cardiol (Engl Ed); 2012 Dec; 65(12):1094-100. PubMed ID: 22951089 [TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Grandi AM; Maresca AM; Giudici E; Laurita E; Marchesi C; Solbiati F; Nicolini E; Guasti L; Venco A Am J Hypertens; 2006 Feb; 19(2):199-205. PubMed ID: 16448893 [TBL] [Abstract][Full Text] [Related]
35. Association of cardiac changes with serum adiponectin and resistin levels in obese and overweight children. Aknc A; Karakurt C; Gurbuz S; Elkran O; Nalbantoglu O; Kocak G; Guldur T; Yologlu S J Cardiovasc Med (Hagerstown); 2013 Mar; 14(3):228-34. PubMed ID: 22441215 [TBL] [Abstract][Full Text] [Related]
36. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy. Olsen MH; Christensen MK; Wachtell K; Tuxen C; Fossum E; Bang LE; Wiinberg N; Devereux RB; Kjeldsen SE; Hildebrandt P; Dige-Petersen H; Rokkedal J; Ibsen H J Hum Hypertens; 2005 Apr; 19(4):301-7. PubMed ID: 15647776 [TBL] [Abstract][Full Text] [Related]
37. Left ventricular hypertrophy in obese hypertensives: is it really eccentric? (An echocardiographic study). Smalcelj A; Puljević D; Buljević B; Brida V Coll Antropol; 2000 Jun; 24(1):167-83. PubMed ID: 10895544 [TBL] [Abstract][Full Text] [Related]
38. Automated versus observer blood pressure as determinants of left ventricular structure. Fagard R; Bielen E; Amery A Eur Heart J; 1992 Oct; 13(10):1373-9. PubMed ID: 1396811 [TBL] [Abstract][Full Text] [Related]
39. Improvement of diastolic function after regression of left ventricular hypertrophy. Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547 [TBL] [Abstract][Full Text] [Related]
40. Uricaemia and left ventricular mass in hypertensive patients. Catena C; Colussi G; Capobianco F; Brosolo G; Sechi LA Eur J Clin Invest; 2014 Oct; 44(10):972-81. PubMed ID: 25186106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]